NeoGenomics, Inc. (NASDAQ:NEO) was the target of a large decrease in short interest in January. As of January 31st, there was short interest totalling 8,454,105 shares, a decrease of 18.9% from the January 15th total of 10,429,700 shares. Based on an average daily volume of 1,066,954 shares, the days-to-cover ratio is presently 7.9 days. Approximately 9.6% of the shares of the company are short sold.
NEO has been the topic of a number of research reports. Zacks Investment Research upgraded shares of NeoGenomics from a “hold” rating to a “buy” rating and set a $14.00 price objective on the stock …Full article